Categories: Sports

India’s Triple-Jumper Aishwarya Babu Banned by NADA for Four Years

India’s top triple-jumper Aishwarya Babu has been banned by the National Anti-Doping Agency’s (NADA) disciplinary panel for four years for using a prohibited anabolic steroid. Aishwarya Babu, 25 years old, was dropped from the Birmingham Commonwealth Games in 2022, along with sprinter S Dhanalakshmi after testing positive for the steroid, which is on the World Anti-Doping Agency’s (WADA) prohibited list.

Aishwarya has been given time till 6th March 2023 to file an appeal against the ban after receiving the ban notice from NADA’s Appeal Panel on 13th February 2023.

Buy Prime Test Series for all Banking, SSC, Insurance & other exams

India’s Triple-Jumper Aishwarya Babu Banned by NADA for Four Years – Key Points

  • Aishwarya previously won the triple jump gold in the championships with a national record-breaking lunge of 14.14 meters.
  • She tested positive for Ostarine — a drug that falls in the category of selective androgen receptor modulator (SRAM) —  during the National Inter-State Championships on 13 and 14 J in 2022 in Chennai.
  • Aishwarya was provisionally suspended in July last year and she has already served six months of her four-year ban.
  • NADA stated that the substance Aishwarya used was an “anabolic steroid” listed under WADA’s 2022 prohibited. It added that the athlete had not taken a therapeutic use exemption (TUE) for it.
  • Aishwarya on the other hand stated in her submission that she “did not take any prohibited ton order to enhance” her performance.
  • The athlete added that she had suffered an injury in the past when her shoulder had dislocated while lifting weights in the gym in February 2021.
  • Aishwarya added that in the run-up to the National Inter-state Championships, she pushed herself too much, which led her to the “painful discomfort on the Shoulder.”
  • NADA’s disciplinary panel questioned why Aishwarya did not approach a hospital or a registered medical practitioner for treatment, adding that the athlete “totally disregarded the rule and took Ostathe rine tablets on advice of her colleague.”
  • The athlete has failed to satisfy the panel that the ADRV (Anti-Doping Rule Violation) was non-intentional as per NADA.

Also Read:

Find More Sports News Here

 

 

Mahesh Kumar

Working as an SEO Manager at Adda247, I bring over 10 years of experience in Search Engine Optimization (SEO) and digital marketing. I specialize in driving organic growth through data-driven strategies, including keyword research, on-page SEO, off-page optimization, and technical SEO. My area of expertise in the EdTech sector, specifically focusing on competitive exams such as Bank, SSC, Railway, UPSC, and various State Government job examinations.

Recent Posts

Sowcar Janaki Dies at 94: Remembering a Legendary Career

Renowned Indian actress Sowcar Janaki breathed her last at the age of 94 on August…

12 hours ago

PM-AASHA Scheme 2026: Objectives, MSP Benefits, Components and Latest Updates

Pradhan Mantri Annadata Aay Sanrakshan Abhiyan (PM-AASHA) is an initiative of the central government that…

12 hours ago

Who Is Yu Zidi? Meet the 13-Year-Old Chinese Swimmer Set to Feature in Asian Games 2026

Many of the finest sport athletes of Asia will be participating in the Asian Games…

14 hours ago

What Is Analogue Paneer? Why States Are Banning It and What Consumers Need to Know

Paneer is one of the most popular and widely used ingredients in India. However, recently…

14 hours ago

Ashutosh Parida to Receive Sarala Puraskar 2026 for Poetry

Prominent Odia poet, essayist, and former scientist at CSIR-IMMT, Ashutosh Parida has been chosen for…

15 hours ago

RBI Appoints S Somanath, Reappoints Anand Mahindra to Central Board

The Reserve Bank of India has named former chairman of the Indian Space Research Organisation,…

15 hours ago